EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

Core Viewpoint - EUDA Health Holdings Limited has amended its warrant agreement with Streeterville Capital, reducing the exercise price and minimum closing price for forced exercise, which may enhance the attractiveness of the warrant for investors [3]. Group 1: Warrant Transaction Background - On November 26, 2025, EUDA entered into a securities purchase agreement with Streeterville Capital for a warrant exercisable into up to 2,000,000 newly issued ordinary shares for an aggregate purchase price of US$100,000 [2]. - The warrant was issued on December 4, 2025, and can be exercised for cash for 90 days from the issuance date, after which a cashless exercise will occur if not exercised [2]. Group 2: Amended Terms - The Warrant Amendment, effective December 16, 2025, reduces the exercise price from US$6.00 to US$4.00 per share [3]. - The minimum closing price required to trigger a "Forced Exercise" has been reduced from US$7.50 to US$6.00 [3]. Group 3: Company Overview - EUDA Health Holdings Limited is a leading non-invasive healthcare provider in Asia, focusing on Singapore, Malaysia, and China [4]. - The company aims to address the healthcare needs of over 1.8 billion people in the region, with a strategic focus on the growing longevity sector [4]. - EUDA is positioned to transform regional healthcare from reactive treatment to proactive, longevity-focused care [4].